Author

Michael Telias

University of California, BerkeleyORCID 0000-0002-7632-6942Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Neuroscience· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Richard KrämeriD· 2 shared Arjit MisraiD· 1 shared Benjamin E. SmithiD· 1 shared Bristol Denlinger· 1 shared Daniel Frozenfar· 1 shared Jared Endres· 1 shared Kevin K. SitiD· 1 shared Leonor Afrima· 1 shared

Activity by Year

2022-2026 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

Richard KrämerORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The P2X7 receptor is an intermediate in the retinoic acid-signaling pathway that induces neuronal remodeling in retinitis pigmentosa

Michael Telias, Leonor Afrima, Jared Endres, Bristol Denlinger, Richard Krämer

This paper identifies the P2X7 receptor as an intermediary in RA signaling that induces neuronal remodeling in retinitis pigmentosa, showing its role in RGC hyperactivity and hyperpermeability.

bioRxiv · May 31, 2026 · PreprintNeuroscience

Inhibiting retinoic acid mitigates vision loss in a mouse model of retinal degeneration

Michael Telias, Kevin K. Sit, Daniel Frozenfar, Benjamin E. Smith, Arjit Misra, Michael J. Goard, Richard Krämer

The paper shows that inhibiting retinoic acid (RA) reduces retinal ganglion cell (RGC) hyperactivity and improves image detection in a mouse model of retinal degeneration.

Science Advances · Mar 18, 2022Peer-reviewedNeuroscience